HCG Engaged for new product route to market // c2i
C2i Case Study Overview
C2i, Connect 2 Inject, came to fruition after Dr. Michael Berend and Kurt Kramer were granted a utility patent for their dual-chambered syringe concept. HCG has been entrusted to find possible partners within the global syringe market or biopharmaceutical arena to assist with bringing such cutting edge technology to market.
Confidential Case Study
The ongoing confidential nature surrounding C2i's IP does not allow full disclosure at this time. However, one can click the link below to sign an NDA to learn 1) more about the advantages of pre-filled syringe technology 2) other HCG conceptualization to market tactics.